Skip to main content
HANDOK Inc. logo

HANDOK Inc. — Investor Relations & Filings

Ticker · 002390 ISIN · KR7002390003 KO Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2024-04-22 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 002390

About HANDOK Inc.

https://www.handok.co.kr/en/

Handok Inc. is a total healthcare company that develops, manufactures, and distributes a comprehensive range of healthcare solutions. Its portfolio includes prescription drugs, general medicine, medical devices, and in-vitro diagnostics. The company's core business focuses on therapeutic areas such as diabetes, cardiovascular and musculoskeletal diseases, and psychoneurotic disorders, in addition to human vaccines. Positioning itself as a "Health Innovator," Handok provides products and services aimed at prevention, diagnosis, and health management. The company collaborates with global enterprises and manages the entire value chain from sourcing and development to commercialization.

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Handok Inc. regarding a correction to a previously filed 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details changes to the number of shares and beneficiaries of stock options. Since this document does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for capital changes), and it is a formal regulatory disclosure filed with the Financial Services Commission/Korea Exchange, it falls under the 'Regulatory Filings' category.
2024-04-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding the granting of stock options (주식매수선택권 부여). It details changes to the number of recipients and the number of shares granted, which are typical of regulatory filings related to corporate capital and equity incentive plans. Since it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for general capital changes), and it is a formal regulatory disclosure filed with the financial authorities, it falls under the 'Regulatory Filings' category.
2024-04-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically functions as a '정정신고' (Amendment Report) to a previously filed stock option grant. This type of filing relates to changes in capital structure and equity-based compensation, which falls under the category of 'Regulatory Filings' (RNS) as it is a specific corporate disclosure to the financial authorities (Financial Services Commission/Korea Exchange) that does not fit into the more specific categories like 'Director's Dealing' or 'Share Issue'.
2024-04-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is a correction (정정신고) to a previous filing. It details changes to stock option grants, including the cancellation of previously granted options for specific individuals. This type of filing, which relates to corporate capital structure and equity-based compensation adjustments, falls under the 'Regulatory Filings' category as it is a specific corporate disclosure required by the Financial Services Commission/Korea Exchange that does not fit into the other specialized categories like 'Director's Dealing' (which is for personal trades) or 'Remuneration Information' (which is for executive compensation reports).
2024-04-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details changes to the number of recipients and the number of shares granted due to cancellations. In the context of financial filings, reports concerning the issuance or modification of stock options, especially those involving capital structure changes or equity-based compensation adjustments, are classified under 'Share Issue/Capital Change' (SHA) as they represent changes to the company's equity instruments.
2024-04-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is a '정정신고' (Correction Report). It details changes to stock option grants, including the number of shares and the list of recipients. This type of filing relates to capital structure and equity compensation, which falls under the category of 'Share Issue/Capital Change' (SHA) in the provided schema, as it pertains to the issuance and modification of equity-based instruments.
2024-04-22 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.